NEW YORK (GenomeWeb) – Exiqon today reported a 10 percent increase year over year in its third quarter revenues.

For the three months ended Sept. 30, Exiqon's total revenues increased to DKK 38.4 million ($5.7 million) from DKK 34.8 million in the prior-year period.

In a statement, the Danish firm said that product sales increased 29 percent to DKK 24.7 million from DKK 19.1 million in 2014.

The firm's net income for the quarter was down to DKK 727,000, or DKK .02 per share, compared to a profit of DKK 1.7 million, or DKK .04 per share, in Q3 2014.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.